United Therapeutics Corp’s recent filing unveils that its Director MALCOLM JAN unloaded Company’s shares for reported $24149.0 on Dec 11 ’25. In the deal valued at $482.98 per share,50 shares were sold. As a result of this transaction, MALCOLM JAN now holds 470 shares worth roughly $0.23 million.
Then, MAHON PAUL A sold 11,000 shares, generating $5,331,316 in total proceeds. Upon selling the shares at $484.67, the EVP & GENERAL COUNSEL now owns 36,781 shares.
Before that, ROTHBLATT MARTINE A sold 4,000 shares. United Therapeutics Corp shares valued at $1,962,783 were divested by the Chairperson & CEO at a price of $490.70 per share. As a result of the transaction, ROTHBLATT MARTINE A now holds 130 shares, worth roughly $64218.700000000004.
Wells Fargo initiated its United Therapeutics Corp [UTHR] rating to an Underweight in a research note published on October 20, 2025; the price target was $414. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who began to cover the stock in late September with a ‘”an Outperform”‘ rating. Cantor Fitzgerald began covering UTHR with “an Overweight” recommendation on June 02, 2025. Wells Fargo revised its rating on April 25, 2025. It rated UTHR as “an Equal weight” which previously was an “an Overweight”.
Price Performance Review of UTHR
On Friday, United Therapeutics Corp [NASDAQ:UTHR] saw its stock jump 1.12% to $493.99. Over the last five days, the stock has gained 0.96%. United Therapeutics Corp shares have risen nearly 36.37% since the year began. Nevertheless, the stocks have risen 40.00% over the past one year. While a 52-week high of $492.62 was reached on 12/12/25, a 52-week low of $266.98 was recorded on 04/09/25.
Levels Of Support And Resistance For UTHR Stock
The 24-hour chart illustrates a support level at 489.58, which if violated will result in even more drops to 485.18. On the upside, there is a resistance level at 497.56. A further resistance level may holdings at 501.14.
How much short interest is there in United Therapeutics Corp?
A steep rise in short interest was recorded in United Therapeutics Corp stocks on 2025-11-28, growing by 85649.0 shares to a total of 1.77 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-31 was 1.68 million shares. There was a rise of 4.84%, which implies that there is a positive sentiment for the stock.
